About Techbankmed
Techbankmed is a company based in Shanghai (China) founded in 2017. Techbankmed has raised $14.93 million across 1 funding round from investors including Puhua Capital. Techbankmed offers products and services including SAFER Esophageal Retractor and Cardiovascular Innovation Services.
- Headquarter Shanghai, China
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
- Legal Name 上海科库医疗技术有限公司
- Jurisdiction Na, Maharashtra, India
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$14.93 M (USD)
in 1 rounds
-
Latest Funding Round
$14.93 M (USD), Series B
Jul 05, 2022
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Techbankmed
Techbankmed offers a comprehensive portfolio of products and services, including SAFER Esophageal Retractor and Cardiovascular Innovation Services.
This device is used for esophageal retraction in medical procedures and was approved under special review processes.
Services for developing and commercializing cardiovascular technologies are provided through partnerships and intellectual property management.
Funding Insights of Techbankmed
Techbankmed has successfully raised a total of $14.93M through 1 strategic funding round. The most recent funding activity was a Series B round of $14.93 million completed in July 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series B — $14.9M
-
First Round
First Round
(05 Jul 2022)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2022 | Amount | Series B - Techbankmed | Valuation | Puhua Capital |
|
Investors in Techbankmed
Techbankmed has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Puhua Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Health and technology startups are invested in by Puhua Capital.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Techbankmed
Financial Statements - Techbankmed
Techbankmed Comparisons
Competitors of Techbankmed
Latest news on Techbankmed
Frequently Asked Questions about Techbankmed
Techbankmed was founded in 2017 and raised its 1st funding round 5 years after it was founded.
Techbankmed is headquartered in Shanghai, China.
Techbankmed is a funded company, having raised a total of $14.93M across 1 funding round to date. The company's 1st funding round was a Series B of $14.93M, raised on Jul 05, 2022.
Techbankmed was established in 2017 in Shanghai, China, as a manufacturer within the medical devices sector. Auxiliary devices designed for cardiac interventional surgery are produced, supporting procedures in healthcare settings. Operations are centered on development and production of these specialized tools, with a focus on the interventional cardiology field. The company serves markets through its domain, techbankmed.com, based in the Asia-Pacific region.
Techbankmed offers SAFER Esophageal Retractor and Cardiovascular Innovation Services.
Techbankmed has 1 investor. Key investors include Puhua Capital.